A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 28,928 shares of PCRX stock, worth $506,240. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,928
Previous 13,541 113.63%
Holding current value
$506,240
Previous $395,000 109.37%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $392,368 - $484,844
15,387 Added 113.63%
28,928 $827,000
Q1 2024

May 15, 2024

SELL
$27.7 - $35.48 $226,779 - $290,474
-8,187 Reduced 37.68%
13,541 $395,000
Q4 2023

Feb 14, 2024

SELL
$26.32 - $34.31 $15,502 - $20,208
-589 Reduced 2.64%
21,728 $733,000
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $98,268 - $128,408
3,203 Added 16.76%
22,317 $684,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $47.5 $409,420 - $538,412
-11,335 Reduced 37.23%
19,114 $765,000
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $1.08 Million - $1.32 Million
30,449 New
30,449 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $56,210 - $64,602
1,097 Added 27.55%
5,079 $270,000
Q2 2022

Aug 15, 2022

SELL
$51.49 - $81.64 $130,063 - $206,222
-2,526 Reduced 38.81%
3,982 $232,000
Q1 2022

May 16, 2022

SELL
$60.03 - $76.49 $1.08 Million - $1.38 Million
-18,066 Reduced 73.52%
6,508 $497,000
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $201,378 - $261,157
4,198 Added 20.6%
24,574 $1.48 Million
Q3 2021

Nov 15, 2021

BUY
$54.64 - $61.3 $699,064 - $784,272
12,794 Added 168.74%
20,376 $1.14 Million
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $17,813 - $21,066
301 Added 4.13%
7,582 $460,000
Q1 2021

May 17, 2021

SELL
$59.31 - $78.82 $280,299 - $372,503
-4,726 Reduced 39.36%
7,281 $510,000
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $6,914 - $9,077
137 Added 1.15%
12,007 $718,000
Q3 2020

Nov 16, 2020

SELL
$51.97 - $63.0 $90,012 - $109,116
-1,732 Reduced 12.73%
11,870 $714,000
Q2 2020

Aug 13, 2020

SELL
$30.8 - $52.47 $1.44 Million - $2.45 Million
-46,637 Reduced 77.42%
13,602 $714,000
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $897,241 - $1.6 Million
31,593 Added 110.29%
60,239 $2.02 Million
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $808,623 - $1.04 Million
-22,270 Reduced 43.74%
28,646 $1.3 Million
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $269,981 - $340,619
7,571 Added 17.47%
50,916 $1.94 Million
Q2 2019

Aug 14, 2019

BUY
$36.57 - $47.97 $1.28 Million - $1.69 Million
35,137 Added 428.08%
43,345 $1.89 Million
Q1 2019

May 15, 2019

BUY
$36.47 - $42.17 $299,345 - $346,131
8,208 New
8,208 $312,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $802M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.